Retraction: Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species‑mediated mitochondrial signaling pathways (Oncol Rep (2011) 26 (1287‑1294) DOI: 10.3892/or.2011.1367);Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species-mediated mitochondrial signaling pathways

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1287-1294

  Chen, Dan ^a   Cao, Jianguo ^a   Tian, Li ^a   Liu, Fei ^a   Sheng, Xifeng ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Casticin; Human cervical cancer; Mitochondria; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CASTICIN; CYTOCHROME C; HERBACEOUS AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER CELL; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

EID: 80053168978     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2022.8448     Document Type: Erratum

References (44)

1. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26: 5802-5812, 2008.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
3. Choudhury P: Preventing cervical cancer: pediatricians role. Indian Pediatr 46: 201-203, 2009.
4. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001. (Pubitemid 32911406)
5. Baker SJ, Fearon ER, Nigro JM, et al: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221, 1989. (Pubitemid 19110302)
6. Ashcroft M and Vousden KH: Regulation of p53 stability. Oncogene 18: 7637-7643, 1999. (Pubitemid 30052690)
7. Bordon E, Henriquez Hernandez LA, Lara PC, et al: Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs). Radiat Oncol 4: 58, 2009.
8. Shi YJ, Zeng K, Li GF, et al: Effects of podophyllotoxin solid lipid nanoparticles on proliferation and apoptosis of cervical carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao 28: 786-788, 2008 (In Chinese).
9. The State Pharmacopoeia Commission of China, Pharmacopoeia of PRC. Chemical Industry Press, Beijin, 2000.
10. Csupor-Loffler B, Hajdu Z, Zupko I, et al: Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytother Res 23: 672-676, 2009.
11. Ono M, Yanaka T, Yamamoto M, Ito Y and Nohara T: New diterpenes and norditerpenes from the fruits of Vitex rotundifolia. J Nat Prod 65: 537-541, 2002. (Pubitemid 34456939)
12. Diaz F, Chavez D, Lee D, et al: Cytotoxic flavone analogues of vitexicarpin, a constituent of the leaves of Vitex negundo. J Nat Prod 66: 865-867, 2003. (Pubitemid 36782101)
13. Ko WG, Kang TH, Lee SJ, et al: Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation by inducing apoptosis in human myeloid leukemia cells. Food Chem Toxicol 38: 861-865, 2000. (Pubitemid 32786704)
14. Shen JK, Du HP, Yang M, Wang YG and Jin J: Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88: 743-752, 2009.
15. Miyoshi N, Naniwa K, Yamada T, Osawa T and Nakamura Y: Dietary flavonoid apigenin is a potential inducer of intracellular oxidative stress: the role in the interruptive apoptotic signal. Arch Biochem Biophys 466: 274-282, 2007. (Pubitemid 47451350)
16. Yang XH, Zheng X, Cao JG, Xiang HL, Liu F and Lv Y: 8-Bromo-7- methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16: 3385-3393, 2010.
17. Matsuo M, Sasaki N, Saga K and Kaneko T: Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull 28: 253-259, 2005. (Pubitemid 40880004)
18. Chen YC, Shen SC, Chow JM, Ko CH and Tseng SW: Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 25: 661-670, 2004.
19. Ling YH, Liebes L, Zou Y and Perez-Soler R: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 278: 33714-33723, 2003. (Pubitemid 37553204)
20. Bouaziz C, Sharaf El Dein O, El Golli E, et al: Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 254: 19-28, 2008.
21. Haïdara K, Zamir L, Shi QW and Batist G: The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 242: 180-190, 2006. (Pubitemid 44485312)
22. Kobayakawa J, Sato-Nishimori F, Moriyasu M and Matsukawa Y: G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Lett 208: 59-64, 2004. (Pubitemid 38501784)
23. Li WX, Cui CB, Cai B, Wang HY and Yao XS: Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells. J Asian Nat Prod Res 7: 615-626, 2005. (Pubitemid 40909330)
24. Pirollo KF, Bouker KB and Chang EH: Does p53 status influence tumor response to anticancer therapies? Anticancer Drugs 11: 419-432, 2000.
25. Kok SH, Cheng SJ, Hong CY, et al: Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett 217: 43-52, 2005.
26. Reuter S, Eifes S, Dicato M, Aggarwal BB and Diederich M: Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76: 1340-1351, 2008.
27. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002. (Pubitemid 37328916)
28. Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437-441, 2009.
29. Leibowitz B and Yu J: Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 9: 417-422, 2010.
30. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D and Reed JC: Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002, 1998. (Pubitemid 28208539)
31. Antonsson B, Montessuit S, Lauper S, Eskes R and Martinou JC: Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 345: 271-278, 2000. (Pubitemid 30077167)
32. Yang JC and Cortopassi GA: Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med 24: 624-631, 1998. (Pubitemid 28150480)
33. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA and Lemasters JJ: The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18: 6353-6364, 1998. (Pubitemid 28500525)
34. Demarchi F and Brancolini C: Altering protein turnover in tumor cells: new opportunities for anti-cancer therapies. Drug Resist Updat 8: 359-368, 2005. (Pubitemid 43358059)
35. Munshi A, Pappas G, Honda T, et al: TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene 20: 3757-3765, 2001. (Pubitemid 32646186)
36. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR and Dou QP: Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 69: 1421-1432, 2005. (Pubitemid 40602442)
37. Appierto V, Tiberio P, Villani MG, Cavadini E and Formelli F: PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation. Carcinogenesis 30: 824-831, 2009.
38. Lin CW, Yang LY, Shen SC and Chen YC: IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells. J Cell Physiol 212: 666-674, 2007.
39. Wei X, Guo W, Wu S, et al: Oxidative stress in NSC-741909-induced apoptosis of cancer cells. J Transl Med 8: 37, 2010.
40. Chen CC and Chan WH: Inhibition of citrinin-induced apoptotic biochemical signaling in human hepatoma G2 cells by resveratrol. Int J Mol Sci 10: 3338-3357, 2009.
41. Kim KK, Lange TS, Singh RK and Brard L: Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells. BMC Cancer 10: 72, 2010.
42. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998. (Pubitemid 28406817)
43. Nunez G, Benedict MA, Hu Y and Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245, 1998. (Pubitemid 29043976)
44. Li P, Nijhawan D, Budihardjo I, et al: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997. (Pubitemid 27508237)